Trial Profile
Pharmacodynamic study of CP-101
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Aspirin/lisinopril/lovastatin (Primary)
- Indications Cardiovascular disorders
- Focus Pharmacodynamics
- Sponsors CardioPharma
- 17 Dec 2015 New trial record
- 15 Dec 2015 According to CardioPharma media release, company is planning to start dosing of patients in the first quarter of 2016. This study has also received an FDA special protocol assessment.